Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key-Reference-Cited by-同舟云学术

Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key

Published:2017-01 Issue:1 Volume:16 Page:94-106
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Norero Blanca,Serrano Carolina A.,Sanchez-Fueyo Alberto,Duarte Ignacio,Torres Javiera,Ocquetau Mauricio,Barrera Francisco,Arrese Marco,Soza Alejandro,Benítez Carlos

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Link

http://publisherspanel.com/icid/pdf/1226820

Reference43 articles.

1. Calcineurin inhibitor-free mycophe-nolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial;Teperman;Liver Transpl,2013

2. Complete weaning off immunosup-pression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence;Tisone;J Hepatol,2006

3. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months;Orlando;Transpl Immunol,2008

4. Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients;Manzia;World J Gastroenterol,2014

5. Infections in human liver recipients: different patterns early and late after transplantation;Barkholt;Trans-pl Int,1993

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Everolimus versus mycophenolate mofetil in liver transplantation: every improvement in renal function matters;Revista Española de Enfermedades Digestivas;2022

2. Rejection and Immunosuppression;Textbook of Liver Transplantation;2022

3. Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade;American Journal of Transplantation;2021-09-27

4. Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus;Transplantation Proceedings;2020-06

5. Modification of immunosuppressive therapy as risk factor for complications after liver transplantation;Best Practice & Research Clinical Gastroenterology;2017-04